ASPIRING | Antiplatelet Secondary Prevention International Randomised study after INtracerebral haemorrhaGe

Watch this 5-minute video about the study.

You might find it useful to:

View the video fullscreen, after pressing play, by clicking the two arrows that appear in the bottom right-hand corner.
Watch it more than once.
Watch it at a slower speed.
Watch it with someone else who can pause, rewind, and discuss it with you.
Read the video transcript.
Make a note of questions you want to ask.

Help us find out if medicines like aspirin protect people with bleeding in the brain from strokes, heart attacks, and death

^*Available from March 2025

I’m interested, but I have questions

I’m not interested, and I want to opt out

Why are we ASPIRING?

Over 20 million people worldwide are living after a stroke due to bleeding in the brain, known as ‘brain haemorrhage’.
They are at risk of clotting or bleeding problems like heart attacks and strokes.
Aspirin and clopidogrel can prevent heart attacks and strokes.
We found that aspirin and clopidogrel were safe after brain haemorrhage.

What’s ASPIRING?

ASPIRING is an international study, testing whether aspirin and clopidogrel prevent strokes, heart attacks, and death after brain haemorrhage. This study, run by The University of Edinburgh and NHS Lothian, will include more than 4,000 people with brain haemorrhage.